Showing results (1-10 of 262) with videos related to

Sort By:
Pageof 27
Annals of Hematology|July 3, 2003
Urinary proteins in multiple myeloma: correlation with clinical parameters and diagnostic implicationsA Corso, P Zappasodi, C Pascutto, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 6, 2002
Urinary proteins and renal dysfunction in patients with multiple myelomaA Corso, P Zappasodi, M Lazzarino
Annals of Hematology|July 6, 2004
Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasoneA Corso, A Lorenzi, V Terulla, et al.
Annals of Hematology|July 11, 2002
Successful therapy with high-dose steroids and cyclosporine for the treatment of carmustine-mediated lung injuryP Zappasodi, P Vitulo, E Volpini, et al.
Leukemia|April 6, 2007
A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myelomaA Corso, M Varettoni, P Zappasodi, et al.
Haematologica|April 6, 1999
Plateau phase in multiple myeloma: an end-point of conventional-dose chemotherapyA Corso, A Nozza, M Lazzarino, et al.
Haematologica|October 30, 1998
Management of acute promyelocytic leukemia relapse in the ATRA eraC Castagnola, M Lunghi, A Corso, et al.
Annals of Hematology|August 25, 1999
Assessment of renal function in patients with multiple myeloma: the role of urinary proteinsA Corso, G Serricchio, P Zappasodi, et al.
Leukemia Research|December 22, 2007
Low efficacy of thalidomide in improving response after induction in multiple myeloma patients who are candidates for high-dose therapyA Corso, S Mangiacavalli, L Barbarano, et al.
Bone Marrow Transplantation|September 1, 2000
Blood stem cell collections in multiple myeloma: definition of a scoring systemA Corso, S Caberlon, G Pagnucco, et al.
Pageof 27